Novo Nordisk (NVO) Operating Margin (2006 - 2026)
Novo Nordisk (NVO) operating margin from Mar 31, 2006 to Mar 31, 2026. The current Novo Nordisk (NVO) operating margin is 61.57%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Operating Margin
Quarterly Operating Margin
Annual Operating Margin change of Novo Nordisk (NVO)
| Year | Operating Margin | Change |
|---|---|---|
| 2025 | 41.30% | -6.54% |
| 2024 | 44.19% | +0.07% |
| 2023 | 44.16% | +4.46% |
| 2022 | 42.28% | +1.50% |
| 2021 | 41.65% | -2.31% |
| 2020 | 42.64% | -0.87% |
| 2019 | 43.01% | +1.80% |
| 2018 | 42.25% | -3.63% |
| 2017 | 43.84% | +1.18% |
| 2016 | 43.33% | -5.42% |
| 2015 | 45.81% | +17.95% |
| 2014 | 38.84% | +3.07% |
| 2013 | 37.68% | -0.24% |
| 2012 | 37.77% | +12.01% |
| 2011 | 33.72% | +8.49% |
| 2010 | 31.08% | +6.32% |
| 2009 | 29.24% | +7.63% |
| 2008 | 27.16% | +27.07% |
| 2007 | 21.38% | -9.17% |
| 2006 | 23.53% | N/A |
Comparison Novo Nordisk (NVO) operating margin with competitors
Novo Nordisk (NVO) operating margin is 61.57%.
| Ticker | Name | Operating Margin | Upside |
|---|---|---|---|
| GILD | Gilead Sciences Inc | 37.16% | -39.65% |
| AMGN | AMGEN Inc | 30.94% | -49.75% |
| GSK | GSK Plc | 30.06% | -51.18% |
| AZN | Astrazeneca plc | 27.77% | -54.90% |
| ABBV | Abbvie Inc | 26.60% | -56.80% |
| JNJ | Johnson & Johnson | 26.58% | -56.83% |
| SNY | Sanofi | 20.18% | -67.23% |
| OGN | Organon & Company | 18.22% | -70.41% |
| GRFS | Grifols SA | 14.65% | -76.21% |